New FDA Guidance Offers Additional Info On eStar Submissions

 
• By Brian Bossetta

The US Food and Drug Administration says its guidance for manufacturers seeking premarket clearance is part of the agency’s overall commitment to improve e-submission consistency and enhance the review process.

FDA LAPTOP.
• Source: Alamy

More from Regulation

More from Policy & Regulation